Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dordain

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Clinical Neuropharmacology|December 1, 1987
Benzodiazepine withdrawal seizures: analysis of 48 case reportsJ Fialip, O Aumaitre, A Eschalier, et al.
Life Sciences|January 1, 1989
Antinociceptive activity of salsolinol (racemate, R(+)-, S(-)-enantiomers): evidence of a peripheral mechanismA Eschalier, F Durif, J Fialip, et al.
Revue Neurologique|February 1, 1972
[Myopathy with mitochondrial abnormalities localizated in type I fibers. Clinical, histochemical and ultrastructural data apropos of a diffuse atrophic form with ocular onset]P Castaigne, D Laplane, M Fardeau, et al.
Therapie|May 1, 1988
[Visual hallucinations and carpipramine]P Clavelou, J Fialip, P Monange, et al.
Revue Neurologique|April 1, 1996
[Neurogenic muscle hypertrophy: 3 cases]D Deffond, P Clavelou, R Colamarino, et al.
Cephalalgia : an International Journal of Headache|June 1, 1985
Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compoundA Pradalier, G Rancurel, G Dordain, et al.
Life Sciences|January 1, 1996
Study of the antinociceptive effect of tetrahydro-papaveroline derivatives. Interaction with opioidsJ Fialip, A Eschalier, F Bétoin, et al.
Therapie|September 1, 1994
[During the treatment or after... drug-induced convulsive accidents. Apropos of 70 cases]M Zenut-Leaud, D Deffond, E Cros, et al.
Revue Neurologique|November 1, 1979
[Subacute sclerosing panencephalitis. A case with a prolonged course in an adult. Isolation and characteristics of a "defective" measles virus (author's transl)]B Schott, G Chazot, G Dordain, et al.
Clinical Neuropharmacology|April 1, 1993
Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's diseaseF Durif, M Paire, D Deffond, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Clinical Neuropharmacology|December 1, 1987
Benzodiazepine withdrawal seizures: analysis of 48 case reportsJ Fialip, O Aumaitre, A Eschalier, et al.
Life Sciences|January 1, 1989
Antinociceptive activity of salsolinol (racemate, R(+)-, S(-)-enantiomers): evidence of a peripheral mechanismA Eschalier, F Durif, J Fialip, et al.
Revue Neurologique|February 1, 1972
[Myopathy with mitochondrial abnormalities localizated in type I fibers. Clinical, histochemical and ultrastructural data apropos of a diffuse atrophic form with ocular onset]P Castaigne, D Laplane, M Fardeau, et al.
Therapie|May 1, 1988
[Visual hallucinations and carpipramine]P Clavelou, J Fialip, P Monange, et al.
Revue Neurologique|April 1, 1996
[Neurogenic muscle hypertrophy: 3 cases]D Deffond, P Clavelou, R Colamarino, et al.
Cephalalgia : an International Journal of Headache|June 1, 1985
Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compoundA Pradalier, G Rancurel, G Dordain, et al.
Life Sciences|January 1, 1996
Study of the antinociceptive effect of tetrahydro-papaveroline derivatives. Interaction with opioidsJ Fialip, A Eschalier, F Bétoin, et al.
Therapie|September 1, 1994
[During the treatment or after... drug-induced convulsive accidents. Apropos of 70 cases]M Zenut-Leaud, D Deffond, E Cros, et al.
Revue Neurologique|November 1, 1979
[Subacute sclerosing panencephalitis. A case with a prolonged course in an adult. Isolation and characteristics of a "defective" measles virus (author's transl)]B Schott, G Chazot, G Dordain, et al.
Clinical Neuropharmacology|April 1, 1993
Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's diseaseF Durif, M Paire, D Deffond, et al.
Pageof 8